PRECOS is a CRO focused on providing clinically relevant oncology models.
PRECOS has a 15 year pedigree of delivering reproducible, patient-relevant in vitro and in vivo oncology models as a business unit of the University of Nottingham. In 2010 PRECOS became a fully independent business to provide a solely commercial service to its clients, whilst maintaining close research links to the University. We combine the innovative research of one of the UK's leading Universities with the scientific background and skills base of a collaborative commercial research organisation to deliver services tailored to a client’s individual needs in a timely fashion, whether as a one-off study or a complete research programme.
PRECOS has unique clinically relevant models, which reflect the patient situation for each aspect of cancer progression encompassing pre-cancerous lesions, primary tumours and metastasis.
Visit our Services sections for a more details of PRECOS’s pre-clinical research and development services. Additional information can be downloaded in the publications section or alternatively contact us.
Latest news and Events
-
LION launched at AACR. A unique panel of patient-derived lung models with key mutations and subtypes. See what all the fuss is about... via @ PRECOSLtd
-
Preparing for AACR. New platforms (PREdict, PREval, PREpare and PREcise) as well as LION (Lung In ONcology) panel of lung models on release. via @ PRECOSLtd
-
Preparing for AACR in Chicago. Book your appointment today to find out about LION: enquiries@precos.co.uk via @ PRECOSLtd
Follow us on: